Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-09-18

AUTHORS

M P Hendriks, N M A Blijlevens, A V M B Schattenberg, D M Burger, J P Donnelly

ABSTRACT

Blood concentrations of cyclosporine A (CsA) ⩾800 μg/l measured 2 h post-dosing, the C2 concentration, is necessary to obtain a maximal pharmacological effect and correlates well with transplant-related complications such as transplant rejection and toxicity. In an open crossover study CsA blood levels were measured during 24 h to generate a pharmacokinetic profile on days 1, 8 and 15 after starting CsA infusion in 21 haematopoietic allogeneic stem cell transplant recipients who were receiving intravenously CsA 3 mg/kg/day either by continuous infusion or by 2 h infusion given every 12 h. C2 levels after the 2 h infusion correlated better than C1 or C3 levels with the area under the concentration-time curve from 0 to 4 h (r2=0.62). C2 levels ⩾800 μg/l were also achieved for 20 out of 24 (83%) of cases after the 2 h infusion of CsA without any increase of CsA-related toxicity but for only three of the 23 patients (13%) after continuous infusion. Therefore, we recommend CsA infusions in 2 h during transplant and perform C2 monitoring to obtain therapeutic C2 levels ⩾800 μg/l. More... »

PAGES

521-525

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bmt.1705481

DOI

http://dx.doi.org/10.1038/sj.bmt.1705481

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050679665

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16981000


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chi-Square Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclosporine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Homologous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hendriks", 
        "givenName": "M P", 
        "id": "sg:person.015404620773.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015404620773.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blijlevens", 
        "givenName": "N M A", 
        "id": "sg:person.01067363064.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067363064.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schattenberg", 
        "givenName": "A V M B", 
        "id": "sg:person.011275053274.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011275053274.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burger", 
        "givenName": "D M", 
        "id": "sg:person.01072452167.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072452167.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Donnelly", 
        "givenName": "J P", 
        "id": "sg:person.0632675422.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632675422.59"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1700745", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005934101", 
          "https://doi.org/10.1038/sj.bmt.1700745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1704273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025343572", 
          "https://doi.org/10.1038/sj.bmt.1704273"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-09-18", 
    "datePublishedReg": "2006-09-18", 
    "description": "Blood concentrations of cyclosporine A (CsA) \u2a7e800\u2009\u03bcg/l measured 2\u2009h post-dosing, the C2 concentration, is necessary to obtain a maximal pharmacological effect and correlates well with transplant-related complications such as transplant rejection and toxicity. In an open crossover study CsA blood levels were measured during 24\u2009h to generate a pharmacokinetic profile on days 1, 8 and 15 after starting CsA infusion in 21 haematopoietic allogeneic stem cell transplant recipients who were receiving intravenously CsA 3\u2009mg/kg/day either by continuous infusion or by 2\u2009h infusion given every 12\u2009h. C2 levels after the 2\u2009h infusion correlated better than C1 or C3 levels with the area under the concentration-time curve from 0 to 4\u2009h (r2=0.62). C2 levels \u2a7e800\u2009\u03bcg/l were also achieved for 20 out of 24 (83%) of cases after the 2\u2009h infusion of CsA without any increase of CsA-related toxicity but for only three of the 23 patients (13%) after continuous infusion. Therefore, we recommend CsA infusions in 2\u2009h during transplant and perform C2 monitoring to obtain therapeutic C2 levels \u2a7e800\u2009\u03bcg/l.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bmt.1705481", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "38"
      }
    ], 
    "keywords": [
      "stem cell transplant recipients", 
      "cell transplant recipients", 
      "h infusion", 
      "C2 level", 
      "CsA infusion", 
      "transplant recipients", 
      "C2 monitoring", 
      "continuous infusion", 
      "haematopoietic stem cell transplant recipients", 
      "allogeneic stem cell transplant recipients", 
      "maximal pharmacological effect", 
      "transplant-related complications", 
      "CsA blood levels", 
      "concentration-time curve", 
      "transplant rejection", 
      "C3 levels", 
      "blood levels", 
      "short infusion", 
      "blood concentrations", 
      "cyclosporine A", 
      "CSA 3", 
      "pharmacological effects", 
      "pharmacokinetic profile", 
      "day 1", 
      "infusion", 
      "recipients", 
      "C2 concentrations", 
      "toxicity", 
      "complications", 
      "levels", 
      "patients", 
      "transplant", 
      "CsA", 
      "days", 
      "concentration", 
      "monitoring", 
      "rejection", 
      "cases", 
      "increase", 
      "effect", 
      "profile", 
      "C1", 
      "curves", 
      "area"
    ], 
    "name": "Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients", 
    "pagination": "521-525", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050679665"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bmt.1705481"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16981000"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bmt.1705481", 
      "https://app.dimensions.ai/details/publication/pub.1050679665"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_422.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bmt.1705481"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705481'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705481'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705481'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705481'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      21 PREDICATES      84 URIs      74 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bmt.1705481 schema:about N06c8b33995414b26821d4ea652f1df5e
2 N630449b28d5b43b4a0f28de2284f3cb9
3 N7450878b95ab4bdb9a1c771db2c3f45d
4 N91ffbff9d4624905bdbd973e7f3a11b2
5 Na9023bf25edb4521b532676e8165838e
6 Nb09bc852c86945719dba64dddce2cf79
7 Nc0713484654b4aed9d515f7868dd23af
8 Nc291247690fc4e148c345e207e0bf24a
9 Nc4fcdc0ca0d04a56a88bb7463d29796c
10 Nce72928eff5b4ef3be18b65726a5e94f
11 Nd6285bd02bfc4346971b435b41159f8b
12 Nfd81c7422bd14ee7b47195428d4f18b4
13 Nfd95e9f558464bf4bf68c989c1cfe54a
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N0b06099059be40db8262703146965e81
17 schema:citation sg:pub.10.1038/sj.bmt.1700745
18 sg:pub.10.1038/sj.bmt.1704273
19 schema:datePublished 2006-09-18
20 schema:datePublishedReg 2006-09-18
21 schema:description Blood concentrations of cyclosporine A (CsA) ⩾800 μg/l measured 2 h post-dosing, the C2 concentration, is necessary to obtain a maximal pharmacological effect and correlates well with transplant-related complications such as transplant rejection and toxicity. In an open crossover study CsA blood levels were measured during 24 h to generate a pharmacokinetic profile on days 1, 8 and 15 after starting CsA infusion in 21 haematopoietic allogeneic stem cell transplant recipients who were receiving intravenously CsA 3 mg/kg/day either by continuous infusion or by 2 h infusion given every 12 h. C2 levels after the 2 h infusion correlated better than C1 or C3 levels with the area under the concentration-time curve from 0 to 4 h (r2=0.62). C2 levels ⩾800 μg/l were also achieved for 20 out of 24 (83%) of cases after the 2 h infusion of CsA without any increase of CsA-related toxicity but for only three of the 23 patients (13%) after continuous infusion. Therefore, we recommend CsA infusions in 2 h during transplant and perform C2 monitoring to obtain therapeutic C2 levels ⩾800 μg/l.
22 schema:genre article
23 schema:isAccessibleForFree false
24 schema:isPartOf N0e4da35ce2af4c6c8e519a737542c9a8
25 N824fe8cb28d04ae8b8b96060c2b19ce3
26 sg:journal.1096890
27 schema:keywords C1
28 C2 concentrations
29 C2 level
30 C2 monitoring
31 C3 levels
32 CSA 3
33 CsA
34 CsA blood levels
35 CsA infusion
36 allogeneic stem cell transplant recipients
37 area
38 blood concentrations
39 blood levels
40 cases
41 cell transplant recipients
42 complications
43 concentration
44 concentration-time curve
45 continuous infusion
46 curves
47 cyclosporine A
48 day 1
49 days
50 effect
51 h infusion
52 haematopoietic stem cell transplant recipients
53 increase
54 infusion
55 levels
56 maximal pharmacological effect
57 monitoring
58 patients
59 pharmacokinetic profile
60 pharmacological effects
61 profile
62 recipients
63 rejection
64 short infusion
65 stem cell transplant recipients
66 toxicity
67 transplant
68 transplant recipients
69 transplant rejection
70 transplant-related complications
71 schema:name Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients
72 schema:pagination 521-525
73 schema:productId N44117254aa65472bafad9fa8bc16118d
74 N78ba7afabdf149e7a58262e527926239
75 N955524cb5935467eb213f173facd4b73
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050679665
77 https://doi.org/10.1038/sj.bmt.1705481
78 schema:sdDatePublished 2022-12-01T06:25
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher Nc01123cc7ead4430a601d0af3c00f1f5
81 schema:url https://doi.org/10.1038/sj.bmt.1705481
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N06c8b33995414b26821d4ea652f1df5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Middle Aged
87 rdf:type schema:DefinedTerm
88 N0b06099059be40db8262703146965e81 rdf:first sg:person.015404620773.06
89 rdf:rest N132b85dbf70b4e41a9f4cfae237ffada
90 N0e4da35ce2af4c6c8e519a737542c9a8 schema:issueNumber 7
91 rdf:type schema:PublicationIssue
92 N132b85dbf70b4e41a9f4cfae237ffada rdf:first sg:person.01067363064.24
93 rdf:rest Nd1d9e1a5bac5492ea3ce81422859d17e
94 N44117254aa65472bafad9fa8bc16118d schema:name doi
95 schema:value 10.1038/sj.bmt.1705481
96 rdf:type schema:PropertyValue
97 N4ea009d293894090b0a0db3ffebade05 rdf:first sg:person.0632675422.59
98 rdf:rest rdf:nil
99 N630449b28d5b43b4a0f28de2284f3cb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Adult
101 rdf:type schema:DefinedTerm
102 N7450878b95ab4bdb9a1c771db2c3f45d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N78ba7afabdf149e7a58262e527926239 schema:name pubmed_id
106 schema:value 16981000
107 rdf:type schema:PropertyValue
108 N824fe8cb28d04ae8b8b96060c2b19ce3 schema:volumeNumber 38
109 rdf:type schema:PublicationVolume
110 N91ffbff9d4624905bdbd973e7f3a11b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Immunosuppressive Agents
112 rdf:type schema:DefinedTerm
113 N955524cb5935467eb213f173facd4b73 schema:name dimensions_id
114 schema:value pub.1050679665
115 rdf:type schema:PropertyValue
116 Na9023bf25edb4521b532676e8165838e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Female
118 rdf:type schema:DefinedTerm
119 Nb09bc852c86945719dba64dddce2cf79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Cross-Over Studies
121 rdf:type schema:DefinedTerm
122 Nbf5629c11b364e53a40ffbb14ea8c714 rdf:first sg:person.01072452167.78
123 rdf:rest N4ea009d293894090b0a0db3ffebade05
124 Nc01123cc7ead4430a601d0af3c00f1f5 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 Nc0713484654b4aed9d515f7868dd23af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Graft vs Host Disease
128 rdf:type schema:DefinedTerm
129 Nc291247690fc4e148c345e207e0bf24a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Hematopoietic Stem Cell Transplantation
131 rdf:type schema:DefinedTerm
132 Nc4fcdc0ca0d04a56a88bb7463d29796c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Chi-Square Distribution
134 rdf:type schema:DefinedTerm
135 Nce72928eff5b4ef3be18b65726a5e94f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cyclosporine
137 rdf:type schema:DefinedTerm
138 Nd1d9e1a5bac5492ea3ce81422859d17e rdf:first sg:person.011275053274.51
139 rdf:rest Nbf5629c11b364e53a40ffbb14ea8c714
140 Nd6285bd02bfc4346971b435b41159f8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 Nfd81c7422bd14ee7b47195428d4f18b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Survival Analysis
145 rdf:type schema:DefinedTerm
146 Nfd95e9f558464bf4bf68c989c1cfe54a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Transplantation, Homologous
148 rdf:type schema:DefinedTerm
149 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
150 schema:name Medical and Health Sciences
151 rdf:type schema:DefinedTerm
152 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
153 schema:name Clinical Sciences
154 rdf:type schema:DefinedTerm
155 sg:journal.1096890 schema:issn 0268-3369
156 1476-5365
157 schema:name Bone Marrow Transplantation
158 schema:publisher Springer Nature
159 rdf:type schema:Periodical
160 sg:person.01067363064.24 schema:affiliation grid-institutes:grid.10417.33
161 schema:familyName Blijlevens
162 schema:givenName N M A
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067363064.24
164 rdf:type schema:Person
165 sg:person.01072452167.78 schema:affiliation grid-institutes:grid.10417.33
166 schema:familyName Burger
167 schema:givenName D M
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072452167.78
169 rdf:type schema:Person
170 sg:person.011275053274.51 schema:affiliation grid-institutes:grid.10417.33
171 schema:familyName Schattenberg
172 schema:givenName A V M B
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011275053274.51
174 rdf:type schema:Person
175 sg:person.015404620773.06 schema:affiliation grid-institutes:grid.10417.33
176 schema:familyName Hendriks
177 schema:givenName M P
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015404620773.06
179 rdf:type schema:Person
180 sg:person.0632675422.59 schema:affiliation grid-institutes:grid.10417.33
181 schema:familyName Donnelly
182 schema:givenName J P
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632675422.59
184 rdf:type schema:Person
185 sg:pub.10.1038/sj.bmt.1700745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005934101
186 https://doi.org/10.1038/sj.bmt.1700745
187 rdf:type schema:CreativeWork
188 sg:pub.10.1038/sj.bmt.1704273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025343572
189 https://doi.org/10.1038/sj.bmt.1704273
190 rdf:type schema:CreativeWork
191 grid-institutes:grid.10417.33 schema:alternateName Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
192 Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
193 schema:name Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
194 Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...